Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Sep;81(2):305–309. doi: 10.1038/sj.bjc.6990692

Colorectal cancer after a negative Haemoccult II® test and programme sensitivity after a first round of screening: the experience of the Department of Calvados (France)

V Bouvier 1, G Launoy 1, C Herbert 1, H Lefevre 1, J Maurel 1,2, M Gignoux 1,2
PMCID: PMC2362867  PMID: 10496357

Abstract

Colorectal cancers emerging after a negative Haemoccult II® are described in the context of a first round of mass screening in the Department of Calvados (France), from April 1991 to the end of December 1994. People with a cancer occurring after a negative test until 31 December 1995 were identified by a local cancer registry. Incidence was calculated and the programme sensitivity was estimated. The incidence of cancer emerging after a negative test was 57.7 per 100 000, i.e. half of the calculated incidence in the reference group (141.6 per 100 000). These cancers did not differ from those of either the non-responder or reference groups, in particular for the stage of extension. The programme sensitivity was globally higher than that estimated in European trials: 77.2, 66.3 and 55.9%, 1, 2 and 3 years after the test respectively. Programme sensitivity was higher for distal colon cancer 1 year after the test, which is probably due to the relatively slow growth of this subsite. © 1999 Cancer Research Campaign

Keywords: colorectal cancer, screening, false-negative test, Haemoccult II®, programme sensitivity

Full Text

The Full Text of this article is available as a PDF (63.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison J. E., Feldman R., Tekawa I. S. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity, and predictive value. Long-term follow-up in a large group practice setting. Ann Intern Med. 1990 Mar 1;112(5):328–333. doi: 10.7326/0003-4819-112-5-328. [DOI] [PubMed] [Google Scholar]
  2. Church T. R., Ederer F., Mandel J. S. Fecal occult blood screening in the Minnesota study: sensitivity of the screening test. J Natl Cancer Inst. 1997 Oct 1;89(19):1440–1448. doi: 10.1093/jnci/89.19.1440. [DOI] [PubMed] [Google Scholar]
  3. Faivre J., Grosclaude P., Launoy G., Arveux P., Raverdy N., Menegoz F., Pienkowski P., Schaffer P., Daures J. P., De Vathaire F. Les cancers digestifs en France. Distribution géographique et estimation de l'incidence nationale. Gastroenterol Clin Biol. 1997;21(3):174–180. [PubMed] [Google Scholar]
  4. Hardcastle J. D., Chamberlain J. O., Robinson M. H., Moss S. M., Amar S. S., Balfour T. W., James P. D., Mangham C. M. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996 Nov 30;348(9040):1472–1477. doi: 10.1016/S0140-6736(96)03386-7. [DOI] [PubMed] [Google Scholar]
  5. Kronborg O., Fenger C., Olsen J., Bech K., Søndergaard O. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol. 1989 Jun;24(5):599–606. doi: 10.3109/00365528909093096. [DOI] [PubMed] [Google Scholar]
  6. Kronborg O., Fenger C., Olsen J., Jørgensen O. D., Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996 Nov 30;348(9040):1467–1471. doi: 10.1016/S0140-6736(96)03430-7. [DOI] [PubMed] [Google Scholar]
  7. Kronborg O., Fenger C., Søndergaard O., Pedersen K. M., Olsen J. Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol. 1987 Aug;22(6):677–686. doi: 10.3109/00365528709011142. [DOI] [PubMed] [Google Scholar]
  8. Launoy G., Herbert C., Reaud J. M., Thezee Y., Tichet J., Maurel J., Ollivier V., Pegulu L., Caces E., Valla A. Haemoccult test properties according to type and number of positive slides in mass screening for colorectal cancer. Br J Cancer. 1995 Oct;72(4):1043–1046. doi: 10.1038/bjc.1995.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Launoy G., Herbert C., Vallée J. P., Desoubeaux N., Réaud J. M., Ollivier V., Bouvier V., Flachs A., Arsène D., Valla A. Le dépistage de masse du cancer colorectal en France. Expérience auprès de 165,000 personnes dans le Calvados. Gastroenterol Clin Biol. 1996;20(3):228–236. [PubMed] [Google Scholar]
  10. Launoy G., Smith T. C., Duffy S. W., Bouvier V. Colorectal cancer mass-screening: estimation of faecal occult blood test sensitivity, taking into account cancer mean sojourn time. Int J Cancer. 1997 Oct 9;73(2):220–224. doi: 10.1002/(sici)1097-0215(19971009)73:2<220::aid-ijc10>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  11. Mandel J. S., Bond J. H., Church T. R., Snover D. C., Bradley G. M., Schuman L. M., Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993 May 13;328(19):1365–1371. doi: 10.1056/NEJM199305133281901. [DOI] [PubMed] [Google Scholar]
  12. Robinson M. H., Moss S. M., Hardcastle J. D., Whynes D. K., Chamberlain J. O., Mangham C. M. Effect of retesting with dietary restriction in Haemoccult screening for colorectal cancer. J Med Screen. 1995;2(1):41–44. doi: 10.1177/096914139500200111. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES